Health
Study evaluates the difference in weight loss caused by two antidiabetic medications – News-Medical.net
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor…
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
The research, which sought to evaluate the difference in weight loss…
Continue Reading
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General16 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase